13 February 2012
Barclays PLC
Director/PDMR shareholding: Disclosure and Transparency Rules 3.1.4R(1)(a)
On 10 February 2012 the following ordinary shares in Barclays PLC ("the Company") were purchased on behalf of the following non-executive Directors of the Company at a price of £2.3801 per share on the London Stock Exchange. As disclosed in the Company's Annual Report, these purchases arise from the policy of using part of each non-executive Director's fee to purchase shares in the Company on the Directors' behalf which, together with any reinvested dividends, are retained for the Director until they leave the Board.
DIRECTOR
|
BARCLAYS PLC SHARES PURCHASED |
TOTAL BENEFICIAL INTEREST FOLLOWING THIS NOTIFICATION |
TOTAL NON-BENEFICIAL INTEREST FOLLOWING THIS NOTIFICATION
|
David Booth |
3,939 |
86,806 |
- |
Alison Carnwath |
3,004 |
47,742 |
- |
Fulvio Conti |
3,955 |
52,455 |
- |
Simon Fraser |
3,630 |
83,144 |
- |
Reuben Jeffery¹ |
5,009 |
77,183 |
- |
Sir Andrew Likierman |
3,357 |
35,686 |
- |
Dambisa Moyo |
3,631 |
11,429 |
- |
Sir Michael Rake |
3,165 |
38,378 |
- |
Sir John Sunderland |
3,129 |
91,187 |
- |
¹ Reuben Jeffery's beneficial interest comprises 15,000 American Depositary Shares and 7,691 Ordinary Shares in Barclays PLC